Results 21 to 30 of about 22,632 (211)

In vivo effects of a GPR30 antagonist [PDF]

open access: yesNature Chemical Biology, 2009
Estrogen is central to many physiological processes throughout the human body. We have previously shown that the G protein-coupled receptor GPR30 (also known as GPER), in addition to classical nuclear estrogen receptors (ER and ER), activates cellular signaling pathways in response to estrogen.
Dennis, Megan K.   +15 more
openaire   +2 more sources

Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα). [PDF]

open access: yesPLoS ONE, 2013
Estrogens and tamoxifen (an antiestrogen) exert their actions by activation of estrogen receptor (ER) through genomic and non-genomic mechanisms and are implicated in the development of endometrial cancer.
Chia-Lung Tsai   +8 more
doaj   +1 more source

Inhibition of GPR30 sensitized gefitinib to NSCLC cells via regulation of epithelial-mesenchymal transition

open access: yesInternational Journal of Immunopathology and Pharmacology, 2023
Introduction: G-protein coupled receptor 30 (GPR30) is associated with cell metastasis and drug resistance in many different cancer cells. The present study aimed to reveal the sensitivity of GPR30 to gefitinib in non-small cell lung cancer (NSCLC) cells.
Xiaomin Yang   +9 more
doaj   +1 more source

GPR30 Contributes to Estrogen-Induced Thymic Atrophy [PDF]

open access: yesMolecular Endocrinology, 2008
The mechanisms by which prolonged estrogen exposures, such as estrogen therapy and pregnancy, reduce thymus weight, cellularity, and CD4 and CD8 phenotype expression, have not been well defined. In this study, the roles played by the membrane estrogen receptor, G protein-coupled receptor 30 (GPR30), and the intracellular estrogen receptors, estrogen ...
Chunhe, Wang   +12 more
openaire   +2 more sources

Estrogen-mediated renoprotection following cardiac arrest and cardiopulmonary resuscitation is robust to GPR30 gene deletion. [PDF]

open access: yesPLoS ONE, 2014
IntroductionAcute kidney injury is a serious,sexually dimorphic perioperative complication, primarily attributed to hypoperfusion. We previously found that estradiol is renoprotective after cardiac arrest and cardiopulmonary resuscitation in ...
Michael P Hutchens   +6 more
doaj   +1 more source

Activation of GPR30 inhibits cardiac fibroblast proliferation [PDF]

open access: yesMolecular and Cellular Biochemistry, 2015
The incidence of left ventricular diastolic dysfunction significantly increases in postmenopausal women suggesting the association between estrogen loss and diastolic dysfunction. The in vivo activation of G protein-coupled estrogen receptor (GPR30) attenuates the adverse effects of estrogen loss on cardiac fibrosis and diastolic dysfunction in mRen2 ...
Hao, Wang   +3 more
openaire   +2 more sources

GPER-induced signaling is essential for the survival of breast cancer stem cells. [PDF]

open access: yes, 2020
G protein-coupled estrogen receptor-1 (GPER), a member of the G protein-coupled receptor (GPCR) superfamily, mediates estrogen-induced proliferation of normal and malignant breast epithelial cells.
Chan, Yu-Tzu   +12 more
core   +2 more sources

G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation. [PDF]

open access: yesPLoS ONE, 2012
Estrogen, the female sex hormone, is known to exert anti-inflammatory and anti-atherogenic effects. Traditionally, estrogen effects were believed to be largely mediated through the classical estrogen receptors (ERs). However, there is increasing evidence
Subhadeep Chakrabarti, Sandra T Davidge
doaj   +1 more source

The Interactions Between GPR30 and the Major Biomarkers in Infiltrating Ductal Carcinoma of the Breast in an Asian Population

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2007
Objective: G-protein-coupled receptor 30 (GPR30) has been reported to be a novel estrogen receptor a (ERa) in vitro. Therefore, the interactions among GPR30, ERa, progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2/neu), and ...
Wen-Hung Kuo   +11 more
doaj   +1 more source

GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo [PDF]

open access: yes, 2015
We have previously demonstrated that estrogen receptor (ER) alpha (ESR1) increases proliferation of adrenocortical carcinoma (ACC) through both an estrogen-dependent and -independent (induced by IGF-II/IGF1R pathways) manner.
Amendola, Donatella   +16 more
core   +2 more sources

Home - About - Disclaimer - Privacy